Natural Product‐Induced Ferroptosis to Overcome Therapy Resistance in Aggressive Cancers
Natural products trigger ferroptosis through iron overload, glutathione depletion, glutathione peroxidase 4 inhibition, and reactive oxygen species accumulation, selectively targeting aggressive, and drug‐resistant cancers. Polyphenols, alkaloids and terpenoids emerge as promising multi‐target agents to overcome therapy resistance and improve future ...
Giorgio Antoniolli
wiley +1 more source
Beyond androgen deprivation therapy: Next-generation hormonal therapies and emerging combination approaches in advanced prostate cancer. [PDF]
Paras G, Schweizer MT.
europepmc +1 more source
Temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggest a window of opportunity for checkpoint inhibitor therapy in prostate cancer. [PDF]
Jamroze A +17 more
europepmc +1 more source
The cost-effectiveness of medical versus surgical androgen deprivation therapy for advanced prostate cancer in Tanzania: a Markov model-based analysis. [PDF]
Nyongole O +9 more
europepmc +1 more source
Shared decision-making in prostate cancer treatment: selecting an androgen deprivation therapy option. [PDF]
Collins SP, Maculaitis MC, Chakoian M.
europepmc +1 more source
Tailored Personas of Online Health Information-Seeking Behaviors Among Men With Prostate Cancer Receiving Androgen Deprivation Therapy: Qualitative Study. [PDF]
Hou S +6 more
europepmc +1 more source
Longitudinal [<sup>18</sup>F]FDG PET/MR Assessment of Arterial Inflammation in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy. [PDF]
Xue S +10 more
europepmc +1 more source
Matching-adjusted indirect comparison of enzalutamide versus apalutamide with androgen-deprivation therapy in patients with metastatic hormone-sensitive prostate cancer. [PDF]
Azad AA +9 more
europepmc +1 more source
Muscle mitochondria, function, mass, and quality of life in prostate cancer during androgen deprivation therapy. [PDF]
Caeiro L +12 more
europepmc +1 more source
Correction: Rapid and sustainable deep testosterone reduction predicts effective androgen deprivation therapy for metastatic hormone-sensitive prostate cancer. [PDF]
Wang Z +10 more
europepmc +1 more source

